An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

A man with multiple sclerosis (MS) is about to undertake a feat of physical and mental endurance. Dominic Shadbolt, 53, from ...

Christina Applegate got emotional opening up about her struggle with multiple sclerosis, nearly four years after she was ...

Hauser frets that amid federal cutbacks, young scientists may turn away from medical research, knee-capping health care ...

Background Previous natural history studies highlighted a consistent heterogeneity of disability trajectories among ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...

The University of Oregon now has four confirmed international students who have had their visas revoked based on unspecified ...

The findings indicate that the currently approved 600-mg dose of intravenous ocrelizumab is optimal to significantly slow ...

Two prominent scientists who study multiple sclerosis — Dr. Alberto Ascherio and Dr. Stephen Hauser — are co-winners of a ...

A new study suggests that high doses of vitamin D supplements could help reduce disease activity among multiple sclerosis ...

Tolebrutinib is an oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase inhibitor that modulates peripheral ...

New research led by a St. Michael's Hospital clinician-scientist and published in the New England Journal of Medicine ...